Jeffrey Leathe is a highly experienced executive and corporate director with a proven, global track record of creating sustainable and high value outcomes across a broad array of industries. Most recently, Jeff was CEO and Chairman of the Board at Lantos Technologies where it achieved commercialization in the consumer audio and industrial hearing protection markets under the UVERO brand. As CEO and Chairman of the Board at Biocius Life Sciences, Mr. Leathe was involved in its acquisition by Agilent Technologies. Mr. Leathe served as the Senior Vice President and Chief Financial Officer of BioTrove Inc., and as Executive Vice President, Chief Financial Officer and Treasurer for Apogent Technologies from 1990-2003. Mr. Leathe is a director and chairman of the audit committee for Bottomline Technologies, a NASDAQ-listed software firm. He received his MBA from the University of North Carolina, Chapel Hill, his B.S. from the University of New Hampshire and holds his CPA.
Buyside healthcare investment professional, with extensive equity analysis experience. Differentiated background includes functional experience in sales (Life Science Tools Sector), marketing (Life Science Tools Sector), and basic research (Biotech Sector).Specialties: Clinical trial and legal due diligence on both development-stage and currently marketed products, channel checks, company and product valuation.
Can “Jon” Özbal, Ph.D.
President & CEO, PureHoney Technologies
Dr. Özbal is responsible for much of the development of the RapidFire High-throughput Mass Spectrometry platform, invented at BioTrove, Inc. where he was Vice President and General Manager of the RapidFire business unit. He led the successful spinout of the RapidFire business to form an independent company, Biocius Life Sciences, in 2009 where he served as the Chief Operating Officer. In 2011 Biocius was acquired by Agilent Technologies and Dr. Özbal become Senior Director, RapidFire Products and the senior manager of the Agilent Wakefield, MA facility. He has extensive experience in bioanalytical chemistry, chromatography, spectroscopy and instrumentation design. Previously, Dr. Özbal was on the faculty of the Division of Bioengineering and Environmental Health (now part of the Department of Biological Engineering) at the Massachusetts Institute of Technology. He holds an A.B. with honors from Bowdoin College and a Ph.D. in Toxicology from Massachusetts Institute of Technology.